Skip to main content

ABVX · Abivax S.A. · Webcasts, Transcripts & Audio

Track ABVX — free
$73.84 -6.81 (-8.44%) Q4 2023 earnings call transcript
Market Cap
$7.06B
Shares
87.54M
Volume · Nov 20 11.24M Avg daily vol (3M) 1.13M

Abivax S.A. Webcasts

Earnings calls, investor updates, investor days and conferences for Abivax S.A. (ABVX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-12-14
Abivax S.A. (ABVX) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-12-01
Abivax S.A. (ABVX) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-30
Abivax S.A. (ABVX) November 30, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-09
Abivax S.A. (ABVX) November 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-09-21
Abivax S.A. (ABVX) Q2 2026 Earnings Call
Revenue
1.20M EUR
▲ 9.9% YoY
Diluted EPS
-1.47
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-06-01
Abivax S.A. (ABVX) Q1 2026 Earnings Call
Revenue
1.34M EUR
▲ 35.2% YoY
Diluted EPS
-0.61
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-05-11
Abivax S.A. (ABVX) May 11, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-23
Abivax S.A. (ABVX) Q4 2025 Earnings Call
Revenue
440,000 EUR*
▼ 89.8% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q4
2024-01-25
Abivax S.A. (ABVX) Q4 2023 Earnings Call Transcript
Positive tone Obefazimod Phase 3 ABTECT in ulcerative colitis Follow-on pipeline candidates and preclinical work Enrollment / retention and headache management
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–9 of 9 webcasts
Key facts CIK 1956827 CUSIP 00370M103 13F (30d) 308 filings 297 filers Visit website Investor relations